Seminars in Arthritis and Rheumatism
Volume 26, Issue 5 , Pages 713-723, April 1997

A potential new treatment for rheumatoid arthritis:Thunder god vine*

    MD
  • Peter E. Lipsky (Professor of Internal Medicine and Microbiology)

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Peter E. Lipsky, MD, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75235-8884.
  • , MD
  • Xue-Lien Tao (Instructor of Internal Medicine)

Abstract 

Various extracts of the vinelike plant Tripterygium wilfordii Hook f have beenwidely used in China to treat patients with a number of autoimmune diseases. Although most of the clinical experience has derived from uncontrolled trials, one placebo-controlled double-blind trial has clearly demonstrated efficacy in rheumatoid arthritis. Studies in laboratory animals have indicated that extracts of Tripterygium wilfordii Hook f suppress both immune and inflammatory responses and also effectively treat a number of models of autoimmune disease. More detailed in vitro analysis has indicated that components of Tripterygium wilfordii Hook f suppress immune responses by inhibiting transcription of cytokine genes, including interleukin-2 and gamma interferon. The current status of knowledge of the potential clinical benefit of this herbal remedy and possible mechanisms accounting for its utility are considered in this review.

Tripterygium wilfordii Hook f, herbal remedies, rheumatoid arthritis, immunosuppressive

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

* Supported by the Harold C. Simmons Arthritis ResearchCenter, Southwestern Medical Center, Dallas, TX.

PII: S0049-0172(97)80040-6

Seminars in Arthritis and Rheumatism
Volume 26, Issue 5 , Pages 713-723, April 1997